# A case report of J wave syndrome with abnormal potentials in both right and left ventricles and reversed J wave in lead V1

**Authors:** Yasuyuki Takada, Junichi Kamoshida, Muryo Terasawa, Kazuhiro Satomi, Yoshinao Yazaki

PMC · DOI: 10.1093/ehjcr/ytag078 · 2026-02-03

## TL;DR

A 19-year-old man with J wave syndrome showed abnormal electrical activity in both heart chambers, and treatment reduced his risk of life-threatening arrhythmias.

## Contribution

The case highlights LV posterior wall involvement in J wave syndrome, indicated by an inverted J wave in lead V1.

## Key findings

- Fractionated potentials were found in both RVOT and LV posterior wall.
- Radiofrequency ablation eliminated PVCs and prevented VF recurrence.
- Inverted J waves in V1 disappeared after successful ablation.

## Abstract

Abnormal epicardial potentials in J wave syndrome predominantly involve the right ventricular outflow tract (RVOT), while left ventricular (LV) involvement remains less characterized and associates with increased ventricular fibrillation (VF) risk. We report a case demonstrating an inverted J wave in lead V1, suggesting LV posterior wall substrate rather than typical RVOT involvement.

A 19-year-old man with resuscitated VF received a subcutaneous implantable cardioverter-defibrillator (S-ICD). Despite cilostazol and quinidine therapy, he experienced five appropriate shocks within 6 months. Twelve-lead electrocardiography showed inferior J waves and a negative deflection in V1, suggesting an inverted J wave. Epicardial mapping showed fractionated potentials in both RVOT and LV posterior wall. Pilsicainide administration augmented RVOT potentials while attenuating those in the LV posterior wall. Spontaneous VF was triggered by premature ventricular contractions (PVCs) originating from the LV posterior wall, where prepotentials preceded QRS onset by 50 ms. Radiofrequency applications eliminated the PVCs, followed by anatomical ablation of RVOT fractionated regions. Subsequently, VF was never induced by program stimulation of up to triple extra stimuli. In the post-operative electrocardiogram, inverted J waves in the V1 lead disappeared. At 8 months post-ablation, the patient remained free from VF recurrence without antiarrhythmic medications, and no S-ICD therapies occurred.

This case demonstrates complex electrophysiological manifestations of J wave syndrome, with the inverted J wave in V1 potentially reflecting LV posterior wall substrate. Although the overlapping ablation procedure limited definitive attribution, these findings contribute to understanding the heterogeneous substrates in J wave syndrome.

## Linked entities

- **Chemicals:** cilostazol (PubChem CID 2754), quinidine (PubChem CID 101744), pilsicainide (PubChem CID 4820)
- **Diseases:** ventricular fibrillation (MONDO:0000190)

## Full-text entities

- **Diseases:** VF (MESH:D014693), J wave syndrome (MESH:C563874), PVCs (MESH:D018879), ICD (OMIM:252500)
- **Chemicals:** cilostazol (MESH:D000077407), Pilsicainide (MESH:C042288), quinidine (MESH:D011802), antiarrhythmic medications (-), S (MESH:D013455)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12908182/full.md

---
Source: https://tomesphere.com/paper/PMC12908182